SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Valeant Pharmaceuticals International, Inc. -- VRX

NEW YORK--(BUSINESS WIRE)--

Levi & Korsinsky, LLP announces that it has commenced an investigation of Valeant Pharmaceuticals International, Inc. ("Valeant Pharmaceuticals" or the "Company") VRX concerning possible violations of federal securities laws by certain officers and directors.

On October 14, 2015, Valeant reported that it was subpoenaed by U.S. prosecutors regarding its pricing decisions, drug distribution, and patient assistance programs. On October 21, 2015, Citron Research published a report alleging that Valeant is using pharmacies related to Philidor to store inventory and record the transactions as sales and has "created an entire network of phantom captive pharmacies" to create fake sales of drugs or to avoid scrutiny from auditors. On February 22, 2016, Valeant announced that it would restate its 2014 and 2015 financial results. On February 29, 2016, Valeant disclosed that the SEC is investigating the Company. Then, on March 15, 2016, Valeant cut its 2016 revenue forecast and disclosed that its delay in filing an annual report could mean a default on its $30 million debt.

If you suffered a loss in Valeant and would like additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/vrx.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20160322006375/en/